BiliMetHealth- Energy Metabolism and Brown Adipose Tissue (BAT) Activity in Individuals With Gilbert's Syndrome (GS) and Healthy Controls

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this case-control study is to investigate energy metabolism and brown adipose tissue (BAT) activity in individuals with Gilbert's syndrome (GS) and controls. The main focus of the study is to analyze: 1. the link between bilirubin metabolism and metabolic health. 2. energy metabolism and body composition in individuals with Gilbert's syndrome and control subjects 3. brown adipose tissue activity in Gilbert's syndrome and healthy controls. Participants will undergo the following investigations: 1. cold exposure 2. PET-CT imaging with 18-F-FDG 3. MRI imaging of liver, abdominal fat and muscle 4. blood sampling 5. indirect calorimetry 6. bioelectrical impedance analysis 7. infrared thermography Researchers will compare individuals with GS and control subjects in terms of metabolic health, body composition and BAT activity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• written consent, age between 18 and 65 years of age, liver marker (AST, ALT, GGT) \< 2x of the upper norm range, non-smoker, moderate physical activity, ability to understand the requirements of the course of study

⁃ Cases: (Gilbert-Syndrom):

• Total bilirubin in the blood \> 1.2 mg/dL (17.1 μM)

• Unconjugated (indirect bilirubin) \> 1 mg/dL

⁃ Controls (non-Gilbert-Syndrom):

• Total bilirubin in the blood ≤ 1.2 mg/dL (17.1 μM)

• Unconjugated (indirect bilirubin) ≤ 1 mg/dL

Locations
Other Locations
Austria
Medical University of Vienna
RECRUITING
Vienna
Contact Information
Primary
Karl-Heinz Wagner, Univ.-Prof. Mag.
karl-heinz.wagner@univie.ac.at
+43-1- 4277 - 54930
Backup
Florian Kiefer, MD, PhD
florian.kiefer@meduniwien.ac.at
+43-140400-72690
Time Frame
Start Date: 2024-03-06
Estimated Completion Date: 2027-01-15
Participants
Target number of participants: 80
Treatments
Cases
Cases: (Gilbert-Syndrom):~* Total bilirubin in the blood \> 1.2 mg/dL (17.1 μM)~* Unconjugated (indirect bilirubin) \> 1 mg/dL
Controls
Controls (non-Gilbert-Syndrom):~* Total bilirubin in the blood ≤ 1.2 mg/dL (17.1 μM)~* Unconjugated (indirect bilirubin) ≤ 1 mg/dL
Related Therapeutic Areas
Sponsors
Collaborators: University of Vienna, Griffith University
Leads: Medical University of Vienna

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.